Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Andreoni

Showing results (81-90 of 306) with videos related to

Pageof 31
Sort By:
Infectious Diseases (London, England)|December 29, 2018
An in-depth analysis of nosocomial bloodstream infections due to Gram-negative bacilli: clinical features, microbiological characteristics and predictors of mortality in a 1 year, prospective study in a large tertiary care Italian hospitalDiego Delle Rose, Patrizio Pezzotti, Carla Fontana, et al.
The Journal of Infection|December 6, 2011
Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapyLaura Ceccarelli, Romina Salpini, Loredana Sarmati, et al.
Drug and Alcohol Review|August 24, 2019
Barriers to effective management of hepatitis C virus in people who inject drugs: Evidence from outpatient clinicsSabrina Molinaro, Giuliano Resce, Alfredo Alberti, et al.
Journal of Virological Methods|December 12, 2003
Viral growth assay to evaluate the replicative capacity of HIV-1 isolatesEmanuele Nicastri, Loredana Sarmati, Luca Dori, et al.
AIDS (London, England)|October 18, 2005
Residual viraemia in subjects with chronic HIV infection and viral load < 50 copies/ml: the impact of highly active antiretroviral therapyLucia Palmisano, Marina Giuliano, Emanuele Nicastri, et al.
Medical Microbiology and Immunology|March 11, 2018
Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1-HCV co-infected patients on effective combined anti-HIV treatmentSaverio G Parisi, Samantha Andreis, Carlo Mengoli, et al.
Journal of the American Nutrition Association|February 18, 2021
Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective StudyMarco Infante, Andrea Buoso, Massimo Pieri, et al.
The Journal of Antimicrobial Chemotherapy|August 24, 2007
Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic reviewEmanuele Nicastri, Sebastiano Leone, Claudio Angeletti, et al.
Plos One|February 2, 2023
Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST studyAlessio Aghemo, Marcello Persico, Roberta D'Ambrosio, et al.
The New Microbiologica|October 2, 2015
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014Andrea Antinori, Simone Marcotullio, Massimo Andreoni, et al.
Pageof 31

Showing results (81-90 of 306) with videos related to

Sort By:
Pageof 31
Infectious Diseases (London, England)|December 29, 2018
An in-depth analysis of nosocomial bloodstream infections due to Gram-negative bacilli: clinical features, microbiological characteristics and predictors of mortality in a 1 year, prospective study in a large tertiary care Italian hospitalDiego Delle Rose, Patrizio Pezzotti, Carla Fontana, et al.
The Journal of Infection|December 6, 2011
Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapyLaura Ceccarelli, Romina Salpini, Loredana Sarmati, et al.
Drug and Alcohol Review|August 24, 2019
Barriers to effective management of hepatitis C virus in people who inject drugs: Evidence from outpatient clinicsSabrina Molinaro, Giuliano Resce, Alfredo Alberti, et al.
Journal of Virological Methods|December 12, 2003
Viral growth assay to evaluate the replicative capacity of HIV-1 isolatesEmanuele Nicastri, Loredana Sarmati, Luca Dori, et al.
AIDS (London, England)|October 18, 2005
Residual viraemia in subjects with chronic HIV infection and viral load < 50 copies/ml: the impact of highly active antiretroviral therapyLucia Palmisano, Marina Giuliano, Emanuele Nicastri, et al.
Medical Microbiology and Immunology|March 11, 2018
Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1-HCV co-infected patients on effective combined anti-HIV treatmentSaverio G Parisi, Samantha Andreis, Carlo Mengoli, et al.
Journal of the American Nutrition Association|February 18, 2021
Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective StudyMarco Infante, Andrea Buoso, Massimo Pieri, et al.
The Journal of Antimicrobial Chemotherapy|August 24, 2007
Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic reviewEmanuele Nicastri, Sebastiano Leone, Claudio Angeletti, et al.
Plos One|February 2, 2023
Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST studyAlessio Aghemo, Marcello Persico, Roberta D'Ambrosio, et al.
The New Microbiologica|October 2, 2015
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014Andrea Antinori, Simone Marcotullio, Massimo Andreoni, et al.
Pageof 31